Global Health Ltd

₹ 1,499 5.29%

18 Sep - close price

About

Global Health Limited is one of the largest private multi-specialty tertiary care providers operating in the North and East regions of India. The company has key specialties in cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology.^[1]

Key Points

Hospital Count^[1]
Global Health operates 6 hospitals under the "Medanta" brand in Gurugram, Indore, Ranchi, Lucknow, Patna and Noida. Spanning an area of 5.6 million sq. ft., they have 3,435 installed beds as on Sep 30, 2025. They provide healthcare services in over 30 medical specialties and engage 2,000+ doctors led by highly experienced department heads.

Website BSE NSE

Market Cap ₹ 40,315 Cr.
Current Price ₹ 1,499
High / Low ₹ 1,544 / 955
Stock P/E 81.2
Book Value ₹ 149
Dividend Yield 0.03 %
ROCE 16.4 %
ROE 13.2 %
Face Value ₹ 2.00

Add ratio to table

Edit ratios

Pros

Company has delivered good profit growth of 54.3% CAGR over last 5 years

Cons

Stock is trading at 10.0 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty LargeMidcap 250 Nifty 500 Multicap 50:25:25 Nifty Midcap 150 Nifty MidSmallcap 400 BSE 500 BSE Healthcare Nifty 500 BSE SmallCap Select Index BSE 150 MidCap Index BSE 400 MidSmallCap Index Nifty500 Equal Weight Nifty500 Shariah Nifty MidSmallcap400 50:50 BSE 250 LargeMidCap Index Nifty500 LargeMidSmall Equal-Cap Weighted Nifty Total Market Nifty MidSmall Healthcare BSE 1000 BSE Hospitals Nifty500 Healthcare

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	551	580	565	724	611	665	812	803	882	926	940	961	1,079
	435	452	439	560	479	514	611	608	688	734	766	767	849
Operating Profit	115	128	126	164	132	150	202	195	195	193	174	193	230
OPM %	21%	22%	22%	23%	22%	23%	25%	24%	22%	21%	19%	20%	21%
	27	26	23	30	27	24	19	-24	43	39	-11	36	24
Interest	6	6	6	10	6	5	8	7	6	9	13	13	16
Depreciation	20	22	22	35	23	25	37	38	33	37	48	52	55
Profit before tax	116	127	121	149	130	144	175	126	198	185	103	163	183
Tax %	26%	25%	28%	26%	26%	27%	25%	26%	23%	24%	22%	24%	25%
	86	95	87	109	96	104	131	93	152	140	80	124	137
EPS in Rs	3.21	3.54	3.25	4.08	3.59	3.89	4.89	3.48	5.65	5.22	2.97	4.62	5.11
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	1,277	1,343	1,441	1,472	1,227	1,765	1,974	2,975	3,204	3,709	3,906
	1,158	1,218	1,297	1,253	1,054	1,384	1,551	2,222	2,432	2,946	3,116
Operating Profit	119	125	144	219	173	381	423	753	772	764	790
OPM %	9%	9%	10%	15%	14%	22%	21%	25%	24%	21%	20%
	67	49	64	43	28	35	47	91	41	107	88
Interest	19	24	21	33	29	33	32	51	41	50	51
Depreciation	77	86	91	99	88	87	86	134	150	171	192
Profit before tax	89	64	97	131	84	296	352	659	623	650	635
Tax %	39%	42%	35%	22%	32%	26%	25%	26%	26%	24%
	54	37	63	103	57	219	263	486	462	496	482
EPS in Rs	11.21	7.70	12.81	20.82	11.55	8.64	9.82	18.11	17.18	18.46	17.92
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	3%

Compounded Sales Growth
10 Years:	%
5 Years:	25%
3 Years:	23%
TTM:	24%

Compounded Profit Growth
10 Years:	%
5 Years:	54%
3 Years:	23%
TTM:	-1%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	30%
1 Year:	11%

Return on Equity
10 Years:	12%
5 Years:	15%
3 Years:	15%
Last Year:	13%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	48	48	49	49	50	51	54	54	54	54
Reserves	1,070	1,141	1,230	1,341	1,434	1,689	2,435	2,983	3,444	3,959
	215	201	168	51	228	308	288	424	337	683
	303	318	310	517	291	314	402	523	606	656
Total Liabilities	1,637	1,709	1,758	1,958	2,002	2,361	3,179	3,984	4,441	5,351
	966	1,162	869	929	851	827	810	1,645	1,861	2,903
CWIP	8	7	5	3	4	6	75	280	458	120
Investments	21	0	356	500	626	734	765	362	366	389
	642	540	528	525	521	794	1,529	1,698	1,757	1,939
Total Assets	1,637	1,709	1,758	1,958	2,002	2,361	3,179	3,984	4,441	5,351

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	124	152	193	201	235	431	559	528	573
	-112	-104	-45	-250	-313	-257	-519	-638	-931
	-6	-49	-56	-37	98	404	-379	-94	264
Net Cash Flow	6	-1	92	-86	20	577	-339	-205	-94
Free Cash Flow	34	123	176	178	171	315	335	102	-102
CFO/OP	153%	153%	114%	125%	86%	126%	97%	89%	89%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	31	41	42	37	39	36	32	26	33	38
Inventory Days	36	26	26	37	39	33	34	29	24	23
Days Payable	132	124	142	135	134	84	113	84	81	93
Cash Conversion Cycle	-66	-56	-74	-61	-56	-16	-48	-29	-24	-32
Working Capital Days	-31	-16	-7	-11	-20	-6	-27	-24	-14	-4
ROCE %		6%	8%	11%	7%	17%	16%	23%	20%	16%

Insights

In beta

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Mar 2026

ALOS (Average Length of Stay)
days

	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	x.xx
	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx	xx,xxx
	xx	xx	xx	xx	xx	xx	xx
	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx	x,xxx
	xx,xxx	xx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx	xxx,xxx
	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx	x,xxx,xxx
x,xxx			x,xxx	x,xxx	x,xxx	x,xxx	x,xxx
			xx	xx	xx	xx	xx

Please log in to see hidden values.

ARPOB (Average Revenue Per Occupied Bed)
INR

Bed Occupancy Rate
%

Census Beds (Operational Capacity)
count

In-Patient Volume (IPD)
count

Out-Patient Volume (OPD)
count

Total Beds (Installed Capacity)
count

International Patient Revenue Mix
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

1 Recently

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	33.06%	33.05%	33.04%	33.04%	33.04%	33.03%	33.03%	33.01%	33.01%	33.01%	33.01%	33.00%
	10.69%	11.36%	12.10%	12.94%	12.21%	12.48%	11.76%	11.54%	11.41%	10.54%	10.15%	9.46%
	10.93%	11.15%	10.25%	10.57%	11.11%	10.51%	11.93%	12.20%	12.97%	13.99%	14.76%	16.89%
	45.31%	44.45%	44.60%	43.44%	43.64%	43.98%	43.28%	43.19%	42.56%	42.41%	42.01%	40.55%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.06%	0.06%	0.08%	0.09%
No. of Shareholders	1,16,627	1,24,775	1,66,253	1,55,307	1,49,722	1,48,633	1,54,688	1,56,372	1,55,806	1,51,241	1,47,390	1,40,531

	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	33.08%	33.04%	33.03%	33.01%	33.00%
	9.89%	12.10%	11.76%	10.15%	9.46%
	12.34%	10.25%	11.93%	14.76%	16.89%
	44.67%	44.60%	43.28%	42.01%	40.55%
	0.00%	0.00%	0.00%	0.08%	0.09%
No. of Shareholders	1,07,120	1,66,253	1,54,688	1,47,390	1,40,531

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Annual reports

DRHP

Credit ratings

Concalls

Aug 2026
Transcript PPT REC
May 2026
Transcript PPT REC
Feb 2026
Transcript PPT REC
Nov 2025
Transcript PPT REC
Aug 2025
Transcript PPT
May 2025
Transcript PPT
May 2025

Transcript

AI Summary
PPT
Feb 2025
Transcript PPT REC
Nov 2024
Transcript PPT
Aug 2024
Transcript PPT
May 2024
Transcript PPT
Feb 2024
Transcript PPT
Nov 2023
Transcript PPT
Aug 2023
Transcript PPT
Aug 2023

Transcript

AI Summary
PPT
Jun 2023
Transcript PPT
Feb 2023
Transcript PPT
Dec 2022

Transcript

AI Summary
PPT